Literature DB >> 15615266

Selective effect of imatinib on serum IgM in a patient with CML.

Masayuki Nagasawa, Shuki Mizutani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15615266     DOI： 10.1532/ijh97.04105

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  7 in total

1.  Challenges in oncology. Case 3. Depigmentation in a chronic myeloid leukemia patient treated with STI-571.

Authors:  Pia Raanani; John M Goldman; Isaac Ben-Bassat
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

Review 2.  A developing picture of lymphopoiesis in bone marrow.

Authors:  Jun Hirose; Taku Kouro; Hideya Igarashi; Takafumi Yokota; Nobuo Sakaguchi; Paul W Kincade
Journal:  Immunol Rev       Date:  2002-11       Impact factor: 12.988

Review 3.  Lymphocyte development in neonatal and adult c-Kit-deficient (c-KitW/W) mice.

Authors:  Claudia Waskow; Hans-Reimer Rodewald
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

4.  Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

Authors:  B J Druker; M Talpaz; D J Resta; B Peng; E Buchdunger; J M Ford; N B Lydon; H Kantarjian; R Capdeville; S Ohno-Jones; C L Sawyers
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

5.  Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia.

Authors:  Juan Luis Steegmann; Gemma Moreno; Concepción Aláez; Santiago Osorio; Asunción Granda; Rafael de la Cámara; Eva Arranz; Fernando Gómez Reino; Francisco Rodriguez Salvanés; José María Fernández-Rañada; Cecilia Muñoz
Journal:  Haematologica       Date:  2003-07       Impact factor: 9.941

6.  Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis.

Authors:  Claudia Waskow; Sabine Paul; Corinne Haller; Max Gassmann; Hans-Reimer Rodewald
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

Review 7.  Pharmacology of imatinib (STI571).

Authors:  Elisabeth Buchdunger; Terence O'Reilly; Jeanette Wood
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162
  7 in total
  1 in total

1.  Changes of immunological profiles in patients with chronic myeloid leukemia in the course of treatment.

Authors:  Zuzana Humlová; Hana Klamová; Ivana Janatková; Karin Malíčková; Petra Králíková; Ivan Sterzl; Zdeněk Roth; Eva Hamšíková; Vladimír Vonka
Journal:  Clin Dev Immunol       Date:  2010-12-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.